All Stories

  1. Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models

    Article • European Respiratory Journal, September 2021, European Respiratory Society (ERS)

    Mohsen Sadatsafavi Sadatsafavi

  2. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?

    Article • European Respiratory Journal, August 2020, European Respiratory Society (ERS)

    Mohsen Sadatsafavi Sadatsafavi

  3. Looking at the COPD spectrum through “PRISm”

    Article • European Respiratory Journal, January 2020, European Respiratory Society (ERS)

    Mohsen Sadatsafavi Sadatsafavi

  4. Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2019, Taylor & Francis

    Kate Johnson, Mohsen Sadatsafavi Sadatsafavi, Dr. Tetyana Kendzerska, Hamid Tavakoli

  5. Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada

    Article • Medical Decision Making, January 2019, SAGE Publications

    Mohsen Sadatsafavi Sadatsafavi

  6. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma

    Article • Journal of Asthma, December 2018, Taylor & Francis

    Kate Johnson, Mohsen Sadatsafavi Sadatsafavi

  7. Variation in the symptoms of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2018, Dove Medical Press

    Mohsen Sadatsafavi Sadatsafavi, Kate Johnson, wan tan, Louise Auclair

  8. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease: A Comparative Study of Economic Burden

    Article • Annals of the American Thoracic Society, November 2015, American Thoracic Society

    Mohsen Sadatsafavi Sadatsafavi